Skip to main content

Table 1 Clinical characteristics and parameters of the patients in the equation-development, validation and application groups

From: A method for evaluation of patient-specific lean body mass from limited-coverage CT images and its application in PERCIST: comparison with predictive equation

Parameter

Equation-development group

Validation group

Application group

Men (n=106)

Mean ± SD

Women (n=93)

Mean ± SD

Men (n=54)

Mean ± SD

Women (n=43)

Mean ± SD

Before treatment

Mean ± SD

After treatment

Mean ± SD

Age (year)

53.5 ± 16.7

52.1 ± 14.8

54.0 ± 15.3

53.0 ± 11.6

54.5 ± 14.9

54.5 ± 14.9

Height (cm)

166.6 ± 6.7

156.3 ± 5.9

168.3 ± 6.5

156.6 ± 5.9

167.6 ± 5.6

167.6 ± 5.6

Weight (kg)

63.5 ± 15.1

56.2 ± 9.2

63.6 ± 10.4

55.7 ± 9.5

63.3 ± 9.6

59.6 ± 10.1

BMI (kg/m2)

22.5 ± 3.5

23.0 ± 3.4

22.3 ± 3.2

22.7 ± 3.9

22.4 ± 3.3

21.8 ± 3.5

Blood glucose level (mg/dL)

102.6 ± 15.6

106.2 ± 13.6

Dose of 18F-FDG (mCi)

6.7±0.7

6.5 ± 0.7

Uptake time (min)

60.5±4.3

60.4 ± 4.5